Page 8 - Demo

8 Insight Magazine Winter 2025 NewsRoclanda: the first new class of glaucoma eye drop in nearly30 years Conchita Landa-Font, Training and Engagement Officer, and Professor Anthony Khawaja, Honorary Consultant Ophthalmic Surgeon and Professorof OphthalmologyIn October 2024, something happened in the UK which had never happened before. The National Institute of Health and Care Excellence (NICE), which approves medicines for use in the NHS in England and Wales, published their approval for a new type of glaucoma drop. The last time a new class of eye drop for glaucoma was introduced was around 1996, pre-dating the formation of NICE. The new drop is called Roclanda, and it contains a new type of drop called netarsudil. It also contains latanoprost, which many of you may be familiar with. Netarsudil is from a family of drugs called Rho-kinase inhibitors. They work by improving the flow of fluid out of the eye. Roclanda is made by the pharmaceutical company Santen. %u201cRoclanda works in a different way to other eye drops for glaucoma